(Allergan plc)

	AGN latest price $208.0507 (-0.29%) ($206.1107 - $211.3171) on Wed. Jan. 4, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.19% (three month average)
RSI	88
Latest Price	$208.0507(-0.29%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 1.5% a day on average for past five trading days.
Weekly Trend	AGN advances 4.8% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    XBI(44%)    SPY(43%)    VT(43%)
Factors Impacting AGN price	AGN will decline at least -1.095% in a week (0% probabilities).   VIXM(-29%)    TLT(-15%)    UUP(-14%)    SHY(-3%)    IPO(-3%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.095% (StdDev 2.19%)
Hourly BBV	0 ()
Intraday Trend	-0.6%

5 Day Moving Average	$203.27(2.35%)
10 Day Moving Average	$196.62(5.81%)
20 Day Moving Average	$190.97(8.94%)
To recent high	-11.2%
To recent low	14.4%
Market Cap	$68.594b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed